Fully humanized mouse models for Immuno-Oncology preclinical drug candidate selection [WEBINAR]

TransCure Webinar Series 2022: Immuno-OncologyПодробнее

Current and Novel Immuno-Oncology Drug Evaluation Methods via Humanized Mouse ModelsПодробнее

[Webinar] Immunodeficient Mouse Models for Cancer & Immunotherapy Research: NCG Mice (20220426 1st）Подробнее

Oncology & Immuno Oncology Precision Medicine From Hit Finding to Pre Clinical Candidate SelectionПодробнее

[Webinar] Immunodeficient Mouse Models for Cancer & Immunotherapy Research: NCG Mice (20220426 2nd）Подробнее

Episode 25: Let's Talk Cancer Modeling with PDX MiceПодробнее

Immunodeficient Mouse Models to Support Prolonged Engraftment of Human NK and Tumor CellsПодробнее

Fully humanized mouse models for Immuno-Oncology preclinical drug candidate selectionПодробнее

Humanized M NSG PBMC and CD34+ Mouse Models 2023 | Applied StemCell, Inc.Подробнее

Humanized mice for Immuno-oncologyПодробнее

Webinar: Introduction to In Vivo Platforms for Cancer ImmunotherapyПодробнее

Webinar: Predictive Pre Clinical Oncology Studies Using Patient-Derived Xenograft PlatformsПодробнее

WEBINAR ONCODESIGN: Humanized mouse models to predict the patient response to cancer treatmentsПодробнее

[Webinar] Immunodeficient Mouse Models for Cancer & Immunotherapy Research: NCG Mice (20220426 2nd)Подробнее

Webinar: Exploring Humanized Mouse Models for Diabetes Research and BeyondПодробнее

Brian Soper - Humanized NSGTM Mice for Evaluation of Immuno Oncology TherapeuticsПодробнее

Humanized Mouse Model Options for Autoimmune DiseasesПодробнее

[Webinar] Considering drug MoA when selecting SLE mouse models for preclinical efficacy studiesПодробнее

Humanized Mouse Models for Biomedical Research: Selection and Experimental ImplicationsПодробнее

A novel humanized mouse model for the study of cell therapiesПодробнее

How Humanized Mouse Models Enforce Preclinical Studies in Immuno-OncologyПодробнее